David Kirske
Director of Finance/CFO bei CTI BIOPHARMA CORP.
Profil
David H.
Kirske is currently the CFO, Secretary & Executive Vice President at CTI BioPharma Corp.
He previously held positions as the Chief Financial Officer & Vice President at Helix BioMedix, Inc., Treasurer & Controller at Redhook Ale Brewery, Inc., and Treasurer & Controller at F5, Inc. Mr. Kirske completed his undergraduate degree at the University of Puget Sound.
Aktive Positionen von David Kirske
| Unternehmen | Position | Beginn |
|---|---|---|
| CTI BIOPHARMA CORP. | Director of Finance/CFO | 26.09.2017 |
Ehemalige bekannte Positionen von David Kirske
| Unternehmen | Position | Ende |
|---|---|---|
| HELIX BIOMEDIX, INC. | Director of Finance/CFO | 23.06.2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - |
| F5, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von David Kirske
| University of Puget Sound | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
